When preparing for life as both doctors and parents, new mothers and mothers-to-be suffer significantly less burnout if they’re supported by targeted, well-planned support.
Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.
“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.
Meanwhile, the Maryland State Medical Society is formally urging the administration to reject the mid-year request, contending it will harm patients and providers.
John S. Scales, MD, a vascular and interventional specialist with Radiology Associates of Ocala in central Florida, has agreed to the terms, according to the state.
Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.
Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis.
Performing TAVR on a patient with bicuspid AS can be challenging. Transcatheter aortic root tricuspidization may represent a new treatment strategy for these patients, according to a new first-in-human trial.
When preparing for life as both doctors and parents, new mothers and mothers-to-be suffer significantly less burnout if they’re supported by targeted, well-planned support.